NO177591C - Analogifremgangsmåte for fremstilling av terapeutisk aktive, selektive adenosin-receptormidler - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive, selektive adenosin-receptormidler

Info

Publication number: NO177591C
Authority: NO; Norway
Prior art keywords: therapeutically active; adenosine receptor; analogous process; selective adenosine; receptor agents
Prior art date: 1990-03-26

Application number

NO911200A

Other languages

English (en)

Norwegian (no)

Other versions

NO911200D0 (no

NO177591B (no

NO911200L (no

Inventor

Norton Paul Peet

Nelson Lowell Lentz

Original Assignee

Merrell Dow Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-03-26

Filing date

1991-03-25

Publication date

1995-10-18

1991-03-25 Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma

1991-03-25 Publication of NO911200D0 publication Critical patent/NO911200D0/no

1991-09-27 Publication of NO911200L publication Critical patent/NO911200L/no

1995-07-10 Publication of NO177591B publication Critical patent/NO177591B/no

1995-10-18 Publication of NO177591C publication Critical patent/NO177591C/no

Links

102000009346 Adenosine receptors Human genes 0.000 title 1
108050000203 Adenosine receptors Proteins 0.000 title 1
239000003795 chemical substances by application Substances 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO911200A 1990-03-26 1991-03-25 Analogifremgangsmåte for fremstilling av terapeutisk aktive, selektive adenosin-receptormidler NO177591C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/499,111 US5047534A (en)	1990-03-26	1990-03-26	Selective adenosine receptor agents

Publications (4)

Publication Number	Publication Date
NO911200D0 NO911200D0 (no)	1991-03-25
NO911200L NO911200L (no)	1991-09-27
NO177591B NO177591B (no)	1995-07-10
NO177591C true NO177591C (no)	1995-10-18

Family

ID=23983864

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO911200A NO177591C (no)	1990-03-26	1991-03-25	Analogifremgangsmåte for fremstilling av terapeutisk aktive, selektive adenosin-receptormidler

Country Status (22)

Country	Link
US (1)	US5047534A (de)
EP (1)	EP0449175B1 (de)
JP (1)	JP3181305B2 (de)
KR (1)	KR100195368B1 (de)
CN (1)	CN1032815C (de)
AR (1)	AR247887A1 (de)
AT (1)	ATE156130T1 (de)
AU (1)	AU632914B2 (de)
CA (1)	CA2038747C (de)
DE (1)	DE69127010T2 (de)
DK (1)	DK0449175T3 (de)
ES (1)	ES2107431T3 (de)
FI (1)	FI98461C (de)
GR (1)	GR3025135T3 (de)
HU (1)	HU208824B (de)
IE (1)	IE910982A1 (de)
IL (1)	IL97656A (de)
NO (1)	NO177591C (de)
NZ (1)	NZ237484A (de)
PH (1)	PH27511A (de)
PT (1)	PT97133B (de)
ZA (1)	ZA912038B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5208240A (en) *	1991-03-12	1993-05-04	Merrell Dow Pharmaceuticals Inc.	8-substituted purines as selective adenosine receptor agents
PT628311E (pt) *	1992-07-08	2002-09-30	Kyowa Hakko Kogyo Kk	Derivado de xantina com actividade antidepressiva
WO1994019349A1 (en) *	1993-02-26	1994-09-01	Merrell Dow Pharmaceuticals Inc.	Xanthine derivatives as adenosine a1 receptor antagonists
WO1994025462A1 (en) *	1993-05-03	1994-11-10	The United States Of America, Represented By The	8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
CA2159989C (en) *	1993-05-06	1994-11-24	Norton P. Peet	8-substituted xanthines as selective adenosine receptor agents
US5629298A (en) *	1995-03-13	1997-05-13	University Of Massachusetts Medical Center	Adenosine as a positive inotrop in the compromised heart
GB9819382D0 (en)	1998-09-04	1998-10-28	Cerebrus Ltd	Chemical compounds I
US6258794B1 (en)	1999-12-14	2001-07-10	The Mclean Hospital Corporation	Treatment of mental conditions including depression
ATE481101T1 (de)	2003-06-10	2010-10-15	Kyowa Hakko Kirin Co Ltd	Verfahren zur behandlung von angstzuständen
WO2007036491A1 (de) *	2005-09-30	2007-04-05	Basf Aktiengesellschaft	Verfahren zur herstellung von alpha-substituierten carbonsäuren
US7592461B2 (en) *	2005-12-21	2009-09-22	Bristol-Myers Squibb Company	Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1435916A (en) *	1972-05-11	1976-05-19	Beecham Group Ltd	Pharmaceutical weight-reducing compositions
SE416810C (sv) *	1977-10-14	1982-07-19	Draco Ab	Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
JPS57198544A (en) *	1981-05-28	1982-12-06	Sony Corp	Manufacture of magnetic recording medium
US4593095A (en) *	1983-02-18	1986-06-03	The Johns Hopkins University	Xanthine derivatives
US4772607A (en) *	1986-05-20	1988-09-20	Warner-Lambert Company	Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US4783530A (en) *	1986-11-13	1988-11-08	Marion Laboratories, Inc.	8-arylxanthines
DE8817122U1 (de) *	1988-12-22	1993-02-04	Boehringer Ingelheim Kg, 55218 Ingelheim	Neue Xanthinderivate mit Adenosinantogenistischer Wirkung

1990
- 1990-03-26 US US07/499,111 patent/US5047534A/en not_active Expired - Fee Related
1991
- 1991-03-19 AU AU73537/91A patent/AU632914B2/en not_active Ceased
- 1991-03-19 NZ NZ237484A patent/NZ237484A/xx unknown
- 1991-03-19 ZA ZA912038A patent/ZA912038B/xx unknown
- 1991-03-20 AR AR91319262A patent/AR247887A1/es active
- 1991-03-21 CA CA002038747A patent/CA2038747C/en not_active Expired - Fee Related
- 1991-03-22 PH PH42193A patent/PH27511A/en unknown
- 1991-03-22 IL IL9765691A patent/IL97656A/en not_active IP Right Cessation
- 1991-03-25 DE DE69127010T patent/DE69127010T2/de not_active Expired - Fee Related
- 1991-03-25 PT PT97133A patent/PT97133B/pt not_active IP Right Cessation
- 1991-03-25 FI FI911420A patent/FI98461C/fi active
- 1991-03-25 IE IE098291A patent/IE910982A1/en not_active IP Right Cessation
- 1991-03-25 DK DK91104668.8T patent/DK0449175T3/da active
- 1991-03-25 HU HU91985A patent/HU208824B/hu not_active IP Right Cessation
- 1991-03-25 AT AT91104668T patent/ATE156130T1/de not_active IP Right Cessation
- 1991-03-25 ES ES91104668T patent/ES2107431T3/es not_active Expired - Lifetime
- 1991-03-25 CN CN91101892A patent/CN1032815C/zh not_active Expired - Fee Related
- 1991-03-25 KR KR1019910004660A patent/KR100195368B1/ko not_active Expired - Fee Related
- 1991-03-25 NO NO911200A patent/NO177591C/no not_active IP Right Cessation
- 1991-03-25 EP EP91104668A patent/EP0449175B1/de not_active Expired - Lifetime
- 1991-03-26 JP JP08451291A patent/JP3181305B2/ja not_active Expired - Fee Related
1997
- 1997-10-22 GR GR970402767T patent/GR3025135T3/el unknown

Also Published As

Publication number	Publication date
JPH04221384A (ja)	1992-08-11
AR247887A1 (es)	1995-04-28
CA2038747A1 (en)	1991-09-27
IL97656A0 (en)	1992-06-21
IE910982A1 (en)	1991-10-09
NO911200D0 (no)	1991-03-25
EP0449175A2 (de)	1991-10-02
FI911420A0 (fi)	1991-03-25
CN1032815C (zh)	1996-09-18
NO177591B (no)	1995-07-10
FI98461B (fi)	1997-03-14
DK0449175T3 (da)	1998-02-23
CA2038747C (en)	2002-05-28
ZA912038B (en)	1991-12-24
PH27511A (en)	1993-08-18
GR3025135T3 (en)	1998-02-27
JP3181305B2 (ja)	2001-07-03
ES2107431T3 (es)	1997-12-01
NZ237484A (en)	1993-10-26
DE69127010T2 (de)	1997-11-13
KR910016752A (ko)	1991-11-05
IL97656A (en)	1996-06-18
FI98461C (fi)	1997-06-25
AU632914B2 (en)	1993-01-14
ATE156130T1 (de)	1997-08-15
HUT56570A (en)	1991-09-30
EP0449175B1 (de)	1997-07-30
NO911200L (no)	1991-09-27
US5047534A (en)	1991-09-10
KR100195368B1 (ko)	1999-06-15
PT97133B (pt)	1998-07-31
DE69127010D1 (de)	1997-09-04
FI911420L (fi)	1991-09-27
AU7353791A (en)	1991-10-03
PT97133A (pt)	1991-12-31
CN1055181A (zh)	1991-10-09
EP0449175A3 (en)	1993-01-20
HU208824B (en)	1994-01-28

Similar Documents

Publication	Publication Date	Title
NO176759C (no)	1995-05-24	Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater
FI890652A7 (fi)	1989-08-11	Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
FI913446L (fi)	1992-01-19	Menetelmä valmistaa terapeuttisesti aktiivista 3-(2-substituoitu-3-okso-2,3-dihydropyridatsin-6-yyli)-2-fenyylipyratsolo/1,5-a/pyridiinejä
NO180749C (no)	1997-06-11	Analogifremgangsmåte for fremstilling av terapeutisk aktive benzimidazolsubstituerte derivater
FI890282L (fi)	1989-07-21	Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
ZA909141B (en)	1991-08-28	Therapeutically active chloro substituted benzimidazoles,processes for their preparation as well as their use
FI883050L (fi)	1988-12-25	Menetelmä terapeuttisesti aktiivisten pyranoindolitsinokinoliinijohdannaisten valmistamiseksi
NO179908C (no)	1997-01-08	Analogifremgangsmåte for fremstilling av terapeutisk aktive, carbocykliske adenosinanaloger
FI885153L (fi)	1989-05-13	Menetelmä terapeuttisesti aktiivisten 2',3'-dideoksi-2'-fluorinukleosidien valmistamiseksi
FI930150L (fi)	1993-01-14	Menetelmä terapeuttisesti aktiivisten indolijohdannaisten valmistamiseksi
NO177591C (no)	1995-10-18	Analogifremgangsmåte for fremstilling av terapeutisk aktive, selektive adenosin-receptormidler
NO174959C (no)	1994-08-10	Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater
NO178967C (no)	1996-07-10	Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazin-derivater
FI880467A7 (fi)	1988-08-05	Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI924642L (fi)	1992-10-14	Menetelmä terapeuttisesti aktiivisten 3-indolyylitioasetaattijohdannaisten valmistamiseksi
NO173784C (no)	1994-02-02	Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater
FI884660L (fi)	1989-04-13	Menetelmä terapeuttisesti aktiivisten 2,2-dimetyylikromeenijohdannaisten valmistamiseksi
FI916058A7 (fi)	1992-06-28	Menetelmä terapeuttisesti aktiivisten dihydrobentsofuraanikarboksamidien valmistamiseksi
NO175781C (no)	1994-12-07	Analogifremgangsmåte for fremstilling av terapeutisk aktive tetracykliske forbindelser
FI925260L (fi)	1992-11-19	Menetelmä terapeuttisesti käyttökelpoisten 6-amino-substituoitujen oktahydro-1,7,8-indolitsiinitriolijohdannaisten valmistamiseksi
NO174200C (no)	1994-04-06	Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-imino-6-polyfluoralkoksybenzotiazol-forbindelser
FI911701L (fi)	1991-10-11	Menetelmä terapeuttisesti käyttökelpoisten 2-substituoitujen alkyyli-3-karboksikarbapeneemien valmistamiseksi
NO174668C (no)	1994-06-15	Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,5,6,7 tetranor-4,8-inter-m-fenylen PGI2 derivater
NO176242C (no)	1995-03-01	Analogifremgangsmåte for fremstilling av terapeutisk aktive 5-substituerte ornithinderivater
FI943778L (fi)	1994-08-17	Menetelmä 1,1-dikloori-1-fluorietaanin valmistamiseksi

Legal Events

Date	Code	Title	Description
2003-10-27	MM1K	Lapsed by not paying the annual fees	Free format text: LAPSED IN SEPTEMBER 2003